A meta-analysis of thoracic radiotherapy for small-cell lung cancer

Volume 327:1618-1624		December 3, 1992		Number 23

A meta-analysis of thoracic radiotherapy for small-cell lung cancer

JP Pignon, R Arriagada, DC Ihde, DH Johnson, MC Perry, RL Souhami, O Brodin, RA Joss, MS Kies, B Lebeau, and et al.

Add to Personal Archive

Add to Citation Manager

Notify a Friend

E-mail When Cited

PubMed Citation

Abstract

BACKGROUND. In spite of 16 randomized trials conducted during the past 15 years, the effect of thoracic radiotherapy on the survival of patients with limited small-cell lung cancer remains controversial. The majority of these trials did not have enough statistical power to detect a difference in survival of 5 to 10 percent at five years. This meta-analysis was designed to evaluate the hypothesis that thoracic radiotherapy contributes to a moderate increase in overall survival in limited small-cell lung cancer. METHODS. We collected individual data on all patients enrolled before December 1988 in randomized trials comparing chemotherapy alone with chemotherapy combined with thoracic radiotherapy. Trials that included only patients with extensive disease were excluded. RESULTS. The meta-analysis included 13 trials and 2140 patients with limited disease. A total of 433 patients with extensive disease were excluded. Overall, 1862 of 2103 patients who could be evaluated died; the median follow-up period for the surviving patients was 43 months. The relative risk of death in the combined-therapy group as compared with the chemotherapy group was 0.86 (95 percent confidence interval, 0.78 to 0.94; P = 0.001), corresponding to a 14 percent reduction in the mortality rate. The benefit in terms of overall survival at three years (+/- SD) was 5.4 +/- 1.4 percent. Indirect comparison of early with late radiotherapy and of sequential with non-sequential radiotherapy did not reveal any optimal time for treatment. There was a trend toward a larger reduction in mortality among younger patients: the relative risk of death in the combined-therapy as compared with the chemotherapy group ranged from 0.72 for patients less than 55 years old (95 percent confidence interval, 0.56 to 0.93) to 1.07 (0.70 to 1.64) for patients over 70. CONCLUSIONS. Thoracic radiotherapy moderately improves survival in patients with limited small-cell lung cancer who are treated with combination chemotherapy. Identification of the optimal combination of chemotherapy and radiotherapy will require further trials.

Source Information

Institut Gustave-Roussy, Villejuif, France.

This article has been cited by other articles:

Sorensen, M., Felip, E., On behalf of the ESMO Guidelines Working Group, (2009). Small-cell lung cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up. Ann Oncol 20: iv71-iv72 [Full Text]
Sculier, J. P., Lafitte, J. J., Efremidis, A., Florin, M. C., Lecomte, J., Berchier, M. C., Richez, M., Berghmans, T., Scherpereel, A., Meert, A. P., Koumakis, G., Leclercq, N., Paesmans, M., Van Houtte, P., for the European Lung Cancer Working Party (ELCWP), (2008). A phase III randomised study of concomitant induction radiochemotherapy testing two modalities of radiosensitisation by cisplatin (standard versus daily) for limited small-cell lung cancer. Ann Oncol 19: 1691-1697 [Abstract] [Full Text]
Silvestri, G A, Spiro, S G (2008). Carcinoma of the bronchus 60 years later. Postgrad. Med. J. 84: 182-187 [Full Text]
Sher, T., Dy, G. K., Adjei, A. A. (2008). Small Cell Lung Cancer. Mayo Clin Proc. 83: 355-367 [Abstract] [Full Text]
Socinski, M. A., Bogart, J. A. (2007). Limited-Stage Small-Cell Lung Cancer: The Current Status of Combined-Modality Therapy. JCO 25: 4137-4145 [Abstract] [Full Text]
Samson, D. J., Seidenfeld, J., Simon, G. R., Turrisi, A. T. III, Bonnell, C., Ziegler, K. M., Aronson, N. (2007). Evidence for Management of Small Cell Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition). Chest 132: 314S-323S [Abstract] [Full Text]
Simon, G. R., Turrisi, A. (2007). Management of Small Cell Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition). Chest 132: 324S-339S [Abstract] [Full Text]
Lally, B. E., Urbanic, J. J., Blackstock, A. W., Miller, A. A., Perry, M. C. (2007). Small Cell Lung Cancer: Have We Made Any Progress Over the Last 25 Years?. The Oncologist 12: 1096-1104 [Abstract] [Full Text]
Slotman, B., Faivre-Finn, C., Kramer, G., Rankin, E., Snee, M., Hatton, M., Postmus, P., Collette, L., Musat, E., Senan, S., the EORTC Radiation Oncology Group and Lung Cance, (2007). Prophylactic Cranial Irradiation in Extensive Small-Cell Lung Cancer. NEJM 357: 664-672 [Abstract] [Full Text]
Schild, S. E., Bonner, J. A., Hillman, S., Kozelsky, T. F., Vigliotti, A. P.G., Marks, R. S., Graham, D. L., Soori, G. S., Kugler, J. W., Tenglin, R. C., Wender, D. B., Adjei, A. (2007). Results of a Phase II Study of High-Dose Thoracic Radiation Therapy With Concurrent Cisplatin and Etoposide in Limited-Stage Small-Cell Lung Cancer (NCCTG 95-20-53). JCO 25: 3124-3129 [Abstract] [Full Text]
Gridelli, C., Langer, C., Maione, P., Rossi, A., Schild, S. E. (2007). Lung Cancer in the Elderly. JCO 25: 1898-1907 [Abstract] [Full Text]
Shimizu, T., Sekine, I., Sumi, M., Ito, Y., Yamada, K., Nokihara, H., Yamamoto, N., Kunitoh, H., Ohe, Y., Tamura, T. (2007). Concurrent Chemoradiotherapy for Limited-disease Small Cell Lung Cancer in Elderly Patients Aged 75 Years or Older. Jpn J Clin Oncol 0: hym005v1-5 [Abstract] [Full Text]
Silvestri, G A, Spiro, S G (2006). Carcinoma of the bronchus 60 years later.. Thorax 61: 1023-1028 [Full Text]
Saito, H., Takada, Y., Ichinose, Y., Eguchi, K., Kudoh, S., Matsui, K., Nakagawa, K., Takada, M., Negoro, S., Tamura, K., Ando, M., Tada, T., Fukuoka, M. (2006). Phase II Study of Etoposide and Cisplatin With Concurrent Twice-Daily Thoracic Radiotherapy Followed by Irinotecan and Cisplatin in Patients With Limited-Disease Small-Cell Lung Cancer: West Japan Thoracic Oncology Group 9902. JCO 24: 5247-5252 [Abstract] [Full Text]
Chien, C.-R., Lai, M.-S. (2006). Trends in the Pattern of Care for Lung Cancer and Their Correlation With New Clinical Evidence: Experiences in a University-Affiliated Medical Center. American Journal of Medical Quality 21: 408-414 [Abstract]
Perry, M. C. (2006). Thoracic Radiation Therapy in Limited Stage Small-Cell Lung Cancer: Timing Is Everything...Isn't It?. JCO 24: 3815-3816 [Full Text]
Spiro, S. G., James, L. E., Rudd, R. M., Trask, C. W., Tobias, J. S., Snee, M., Gilligan, D., Murray, P. A., de Elvira, M. C. R., O'Donnell, K. M., Gower, N. H., Harper, P. G., Hackshaw, A. K. (2006). Early Compared With Late Radiotherapy in Combined Modality Treatment for Limited Disease Small-Cell Lung Cancer: A London Lung Cancer Group Multicenter Randomized Clinical Trial and Meta-Analysis. JCO 24: 3823-3830 [Abstract] [Full Text]
Vokes, E. E., Perry, M. C., Kindler, H. L., Green, M. R. (2006). The cancer and leukemia group B respiratory committee.. Clin. Cancer Res. 12: 3581s-3588s [Abstract] [Full Text]
Neerkin, J, Riley, J (2006). Ethical aspects of palliative care in lung cancer and end stage lung disease. Chronic Respiratory Disease 3: 93-101 [Abstract]
De Ruysscher, D., Pijls-Johannesma, M., Vansteenkiste, J., Kester, A., Rutten, I., Lambin, P. (2006). Systematic review and meta-analysis of randomised, controlled trials of the timing of chest radiotherapy in patients with limited-stage, small-cell lung cancer. Ann Oncol 17: 543-552 [Abstract] [Full Text]
De Ruysscher, D., Pijls-Johannesma, M., Bentzen, S. M., Minken, A., Wanders, R., Lutgens, L., Hochstenbag, M., Boersma, L., Wouters, B., Lammering, G., Vansteenkiste, J., Lambin, P. (2006). Time Between the First Day of Chemotherapy and the Last Day of Chest Radiation Is the Most Important Predictor of Survival in Limited-Disease Small-Cell Lung Cancer. JCO 24: 1057-1063 [Abstract] [Full Text]
Thatcher, N., Qian, W., Clark, P. I., Hopwood, P., Sambrook, R. J., Owens, R., Stephens, R. J., Girling, D. J. (2005). Ifosfamide, Carboplatin, and Etoposide With Midcycle Vincristine Versus Standard Chemotherapy in Patients With Small-Cell Lung Cancer and Good Performance Status: Clinical and Quality-of-Life Results of the British Medical Research Council Multicenter Randomized LU21 Trial. JCO 23: 8371-8379 [Abstract] [Full Text]
Giaccone, G., Debruyne, C., Felip, E., Chapman, P. B., Grant, S. C., Millward, M., Thiberville, L., D'addario, G., Coens, C., Rome, L. S., Zatloukal, P., Masso, O., Legrand, C. (2005). Phase III Study of Adjuvant Vaccination With Bec2/Bacille Calmette-Guerin in Responding Patients With Limited-Disease Small-Cell Lung Cancer (European Organisation for Research and Treatment of Cancer 08971-08971B; Silva Study). JCO 23: 6854-6864 [Abstract] [Full Text]
Ettinger, D. S., Berkey, B. A., Abrams, R. A., Fontanesi, J., Machtay, M., Duncan, P. J., Curran, W. J. Jr, Movsas, B., Byhardt, R. W. (2005). Study of Paclitaxel, Etoposide, and Cisplatin Chemotherapy Combined With Twice-Daily Thoracic Radiotherapy for Patients With Limited-Stage Small-Cell Lung Cancer: A Radiation Therapy Oncology Group 9609 Phase II Study. JCO 23: 4991-4998 [Abstract] [Full Text]
Kubota, K., Nishiwaki, Y., Sugiura, T., Noda, K., Mori, K., Kawahara, M., Negoro, S., Watanabe, K., Imamura, F., Tamura, T., Saijo, N. (2005). Pilot Study of Concurrent Etoposide and Cisplatin Plus Accelerated Hyperfractionated Thoracic Radiotherapy Followed by Irinotecan and Cisplatin for Limited-Stage Small Cell Lung Cancer: Japan Clinical Oncology Group 9903. Clin. Cancer Res. 11: 5534-5538 [Abstract] [Full Text]
Rossi, A., Maione, P., Colantuoni, G., Guerriero, C., Ferrara, C., Del Gaizo, F., Nicolella, D., Gridelli, C. (2005). Treatment of Small Cell Lung Cancer in the Elderly. The Oncologist 10: 399-411 [Abstract] [Full Text]
Han, J.-Y., Cho, K. H., Lee, D. H., Kim, H. Y., Kim, E.-A, Lee, S. Y., Lee, J. S. (2005). Phase II Study of Irinotecan Plus Cisplatin Induction Followed by Concurrent Twice-Daily Thoracic Irradiation With Etoposide Plus Cisplatin Chemotherapy for Limited-Disease Small-Cell Lung Cancer. JCO 23: 3488-3494 [Abstract] [Full Text]
Lorigan, P., Woll, P. J., O'Brien, M. E. R., Ashcroft, L. F., Sampson, M. R., Thatcher, N. (2005). Randomized Phase III Trial of Dose-Dense Chemotherapy Supported by Whole-Blood Hematopoietic Progenitors in Better-Prognosis Small-Cell Lung Cancer. JNCI J Natl Cancer Inst 97: 666-674 [Abstract] [Full Text]
Fried, D. B., Morris, D. E., Poole, C., Rosenman, J. G., Halle, J. S., Detterbeck, F. C., Hensing, T. A., Socinski, M. A. (2004). Systematic Review Evaluating the Timing of Thoracic Radiation Therapy in Combined Modality Therapy for Limited-Stage Small-Cell Lung Cancer. JCO 22: 4837-4845 [Abstract] [Full Text]
Le, Q.-T., McCoy, J., Williamson, S., Ryu, J., Gaspar, L. E., Edelman, M. J., Dakhil, S. R., Sides, S. D., Crowley, J. J., Gandara, D. R. (2004). Phase I Study of Tirapazamine Plus Cisplatin/Etoposide and Concurrent Thoracic Radiotherapy in Limited-Stage Small Cell Lung Cancer (S0004): A Southwest Oncology Group Study. Clin. Cancer Res. 10: 5418-5424 [Abstract] [Full Text]
Badzio, A., Kurowski, K., Karnicka-Mlodkowska, H., Jassem, J. (2004). A retrospective comparative study of surgery followed by chemotherapy vs. non-surgical management in limited-disease small cell lung cancer. Eur. J. Cardiothorac. Surg. 26: 183-188 [Abstract] [Full Text]
Brenner, B., Tang, L. H., Klimstra, D. S., Kelsen, D. P. (2004). Small-Cell Carcinomas of the Gastrointestinal Tract: A Review. JCO 22: 2730-2739 [Abstract] [Full Text]
The International Adjuvant Lung Cancer Trial Colla, (2004). Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non-Small-Cell Lung Cancer. NEJM 350: 351-360 [Abstract] [Full Text]
Spira, A., Ettinger, D. S. (2004). Multidisciplinary Management of Lung Cancer. NEJM 350: 379-392 [Full Text]
Movsas, B., Moughan, J., Komaki, R., Choy, H., Byhardt, R., Langer, C., Goldberg, M., Graham, M., Ettinger, D., Johnstone, D., Abrams, R., Munden, R., Starkschall, G., Owen, J. (2003). Radiotherapy Patterns of Care Study in Lung Carcinoma. JCO 21: 4553-4559 [Abstract] [Full Text]
Lee, S.-H., Ahn, Y. C., Kim, H. J., Lim, D. H., Lee, S. I., Nam, E., Park, S. H., Park, J., Lee, K.-E., Park, J. O., Kim, K., Kim, W. S., Jung, C. W., Im, Y.-H., Kang, W. K., Lee, M. H., Park, K. (2003). Early Concurrent Chemoradiotherapy with Prolonged Oral Etoposide and Cisplatin for Limited-stage Small-cell Lung Cancer. Jpn J Clin Oncol 33: 620-625 [Abstract] [Full Text]
Kamel, E. M., Zwahlen, D., Wyss, M. T., Stumpe, K. D., von Schulthess, G. K., Steinert, H. C. (2003). Whole-Body 18F-FDG PET Improves the Management of Patients with Small Cell Lung Cancer. JNM 44: 1911-1917 [Abstract] [Full Text]
Hurria, A., Kris, M. G. (2003). Management of Lung Cancer in Older Adults. CA Cancer J Clin 53: 325-341 [Abstract] [Full Text]
Reck, M., von Pawel, J., Macha, H.-N., Kaukel, E., Deppermann, K.-M., Bonnet, R., Ulm, K., Hessler, S., Gatzemeier, U. (2003). Randomized Phase III Trial of Paclitaxel, Etoposide, and Carboplatin Versus Carboplatin, Etoposide, and Vincristine in Patients With Small-Cell Lung Cancer. JNCI J Natl Cancer Inst 95: 1118-1127 [Abstract] [Full Text]
Booton, R, Jones, M, Thatcher, N (2003). Lung cancer * 7: Management of lung cancer in elderly patients. Thorax 58: 711-720 [Full Text]
Lu, C., Komaki, R., Lee, J. S., Shin, D. M., Palmer, J. L., Coldman, B. J., Pisters, K. M., Kurie, J. M., Fossella, F. V., Glisson, B. S. (2003). A Phase I Study of Topotecan/Paclitaxel Alternating with Etoposide/Cisplatin and Thoracic Irradiation in Patients with Limited Small Cell Lung Cancer. Clin. Cancer Res. 9: 2085-2091 [Abstract] [Full Text]
Price, A (2003). Lung cancer * 5: State of the art radiotherapy for lung cancer. Thorax 58: 447-452 [Abstract] [Full Text]
Simon, G. R., Wagner, H. (2003). Small Cell Lung Cancer. Chest 123: 259S-271S [Abstract] [Full Text]
Sundstrom, S., Bremnes, R. M., Kaasa, S., Aasebo, U., Hatlevoll, R., Dahle, R., Boye, N., Wang, M., Vigander, T., Vilsvik, J., Skovlund, E., Hannisdal, E., Aamdal, S. (2002). Cisplatin and Etoposide Regimen Is Superior to Cyclophosphamide, Epirubicin, and Vincristine Regimen in Small-Cell Lung Cancer: Results From a Randomized Phase III Trial With 5 Years' Follow-Up. JCO 20: 4665-4672 [Abstract] [Full Text]
Shepherd, F. A., Giaccone, G., Seymour, L., Debruyne, C., Bezjak, A., Hirsh, V., Smylie, M., Rubin, S., Martins, H., Lamont, A., Krzakowski, M., Sadura, A., Zee, B. (2002). Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Marimastat After Response to First-Line Chemotherapy in Patients With Small-Cell Lung Cancer: A Trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer. JCO 20: 4434-4439 [Abstract] [Full Text]
Spiro, S. G., Porter, J. C. (2002). Lung Cancer--Where Are We Today?: Current Advances in Staging and Nonsurgical Treatment. Am. J. Respir. Crit. Care Med. 166: 1166-1196 [Abstract] [Full Text]
Tjan-Heijnen, V. C. G., Wagener, D. J. T., Postmus, P. E. (2002). An analysis of chemotherapy dose and dose-intensity in small-cell lung cancer: lessons to be drawn. Ann Oncol 13: 1519-1530 [Abstract] [Full Text]
Takada, M., Fukuoka, M., Kawahara, M., Sugiura, T., Yokoyama, A., Yokota, S., Nishiwaki, Y., Watanabe, K., Noda, K., Tamura, T., Fukuda, H., Saijo, N. (2002). Phase III Study of Concurrent Versus Sequential Thoracic Radiotherapy in Combination With Cisplatin and Etoposide for Limited-Stage Small-Cell Lung Cancer: Results of the Japan Clinical Oncology Group Study 9104. JCO 20: 3054-3060 [Abstract] [Full Text]
Okuno, S. H., Jett, J. R. (2002). Small Cell Lung Cancer: Current Therapy and Promising New Regimens. The Oncologist 7: 234-238 [Abstract] [Full Text]
Arriagada, R., Le Chevalier, T., Riviere, A., Chomy, P., Monnet, I., Bardet, E., Santos-Miranda, J. A, Le Pechoux, C., Tarayre, M., Benhamou, S., Laplanche, A. (2002). Patterns of failure after prophylactic cranial irradiation in small-cell lung cancer: analysis of 505 randomized patients. Ann Oncol 13: 748-754 [Abstract] [Full Text]
Vallieres, E., Machtay, M., Glatstein, E., Bonner, J. A. (2002). Adjuvant Radiation Therapy After Complete Resection of Non-Small-Cell Lung Cancer. JCO 20: 1427-1429 [Full Text]
Osterlind, K. (2001). Chemotherapy in small cell lung cancer. Eur Respir J 18: 1026-1043 [Abstract] [Full Text]
Komaki, R., Chasen, M. H., Travis, W. D., Putnam, J. B., Fossella, F. V., Byhardt, R. W., Ro, J. Y. (2001). Oncodiagnosis Panel: 1999: Cancer of the Lung: Oncodiagnosis. RadioGraphics 21: 1573-1596 [Full Text]
Bremnes, R. M., Sundstrom, S., Vilsvik, J., Aasebo, U. (2001). Multicenter Phase II Trial of Paclitaxel, Cisplatin, and Etoposide With Concurrent Radiation for Limited-Stage Small-Cell Lung Cancer. JCO 19: 3532-3538 [Abstract] [Full Text]
Song, F., Sheldon, T. A., Sutton, A. J., Abrams, K. R., Jones, D. R. (2001). Methods for Exploring Heterogeneity in Meta-Analysis. Eval Health Prof 24: 126-151 [Abstract]
Woo, I. S., Park, Y. S., Kwon, S. H., Park, Y. I., Lee, J. A., Park, M. J., Hyun, I. G., Jung, K. S., Bae, H. S., Oh, D. H., Kim, W. S., Park, K., Park, C. H., Kim, H. J., Ahn, Y. C. (2000). A Phase II Study of VP-16-Ifosfamide-Cisplatin Combination Chemotherapy Plus Early Concurrent Thoracic Irradiation for Previously Untreated Limited Small Cell Lung Cancer. Jpn J Clin Oncol 30: 542-546 [Abstract] [Full Text]
Arriagada, R., Pignon, J.-P. (2000). Is Meta-analysis a Metaphysical or a Scientific Method?. Chest 118: 832-834 [Full Text]
Machtay, M., Kaiser, L. R., Glatstein, E. (2000). Reality and Meta-analyses. Chest 118: 835-836 [Full Text]
Glisson, B., Scott, C., Komaki, R., Movsas, B., Wagner, H. (2000). Cisplatin, Ifosfamide, Oral Etoposide, and Concurrent Accelerated Hyperfractionated Thoracic Radiation for Patients With Limited Small-Cell Lung Carcinoma: Results of Radiation Therapy Oncology Group Trial 93-12. JCO 18: 2990-2995 [Abstract] [Full Text]
Hugli, A., Moro, D., Mermillod, B., Bolla, M., Alberto, P., Bonnefoi, H., Miralbell, R. (2000). Phase II Trial of Up-Front Accelerated Thoracic Radiotherapy Combined With Chemotherapy and Optional Up-Front Prophylactic Cranial Irradiation in Limited Small-Cell Lung Cancer. JCO 18: 1662-1667 [Abstract] [Full Text]
Levitan, N., Dowlati, A., Shina, D., Craffey, M., Mackay, W., DeVore, R., Jett, J., Remick, S. C., Chang, A., Johnson, D. (2000). Multi-Institutional Phase I/II Trial of Paclitaxel, Cisplatin, and Etoposide With Concurrent Radiation for Limited-Stage Small-Cell Lung Carcinoma. JCO 18: 1102-1102 [Abstract] [Full Text]
Elias, A. (1999). Hematopoietic Stem Cell Transplantation for Small Cell Lung Cancer*. Chest 116: 531S-538S [Abstract] [Full Text]
Simmonds, P. (1999). Managing patients with lung cancer. BMJ 319: 527-528 [Full Text]
Carney, D. N. (1999). Prophylactic Cranial Irradiation and Small-Cell Lung Cancer. NEJM 341: 524-526 [Full Text]
Elias, A., Ibrahim, J., Skarin, A. T., Wheeler, C., McCauley, M., Ayash, L., Richardson, P., Schnipper, L., Antman, K. H., Frei, E. III (1999). Dose-Intensive Therapy for Limited-Stage Small-Cell Lung Cancer: Long-Term Outcome. JCO 17: 1175-1175 [Abstract] [Full Text]
Turrisi, A. T., Kim, K., Blum, R., Sause, W. T., Livingston, R. B., Komaki, R., Wagner, H., Aisner, S., Johnson, D. H. (1999). Twice-Daily Compared with Once-Daily Thoracic Radiotherapy in Limited Small-Cell Lung Cancer Treated Concurrently with Cisplatin and Etoposide. NEJM 340: 265-271 [Abstract] [Full Text]
Lichter, A. S., Lawrence, T. S. (1995). Recent Advances in Radiation Oncology. NEJM 332: 371-379 [Full Text]
Smith, G D (1994). Increasing the accessibility of data. BMJ 308: 1519-1520 [Full Text]
Arriagada, R., Le Chevalier, T., Pignon, J.-P., Riviere, A., Monnet, I., Chomy, P., Tuchais, C., Tarayre, M., Ruffie, P. (1993). Initial Chemotherapeutic Doses and Survival in Patients with Limited Small-Cell Lung Cancer. NEJM 329: 1848-1852 [Abstract] [Full Text]
Lau, J., Berlin, J., Chalmers, T. C., Pignon, J.-P., Arriagada, R. (1993). Meta-Analysis of Radiotherapy for Small-Cell Lung Cancer. NEJM 328: 1425-1426 [Full Text]

Comments and questions? Please contact us.